WO2014031721A1 - Fiber scaffolds for enhancing cell proliferation in cell culture - Google Patents

Fiber scaffolds for enhancing cell proliferation in cell culture Download PDF

Info

Publication number
WO2014031721A1
WO2014031721A1 PCT/US2013/055941 US2013055941W WO2014031721A1 WO 2014031721 A1 WO2014031721 A1 WO 2014031721A1 US 2013055941 W US2013055941 W US 2013055941W WO 2014031721 A1 WO2014031721 A1 WO 2014031721A1
Authority
WO
WIPO (PCT)
Prior art keywords
bioreactor
further include
polymer fibers
substrate
fibers
Prior art date
Application number
PCT/US2013/055941
Other languages
French (fr)
Inventor
Jed K. Johnson
Original Assignee
Johnson Jed K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Jed K filed Critical Johnson Jed K
Publication of WO2014031721A1 publication Critical patent/WO2014031721A1/en

Links

Classifications

    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
    • D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
    • D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
    • D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
    • D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/02—Membranes; Filters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/56—Fibrin; Thrombin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2535/00—Supports or coatings for cell culture characterised by topography
    • C12N2535/10—Patterned coating

Definitions

  • FIGS. 13-14 are bar graphs that illustrate enhanced cell growth on nanofiber scaffolds made from a blend of PET and PU compared with plain PET and plain PU using human mesenchymal stem cells;
  • Fiber structures may be placed into the bioreactor at a manufacturing facility, sealed, sterilized, and then shipped to the customer. Alternately, these fiber structures may be sold separately and placed in the bioreactor by a person performing cell culture.
  • fiber is deposited directly onto the bag surface by placing a negatively charged substrate behind the bag or placing an anti-static bar behind the bag. This technique permits uniform deposition of the positively charged fibers onto the bag surface.
  • the fibers may be attached to the bioreactor walls with adhesives, heat, laser welding, ultrasonic welding, or other methods.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Sustainable Development (AREA)
  • Textile Engineering (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

A substrate for culturing cells that includes at least one fiber scaffold adapted to be contained within a disposable or non-disposable bioreactor, wherein the fiber scaffold further includes polymer fibers that have been created by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both.

Description

TITLE OF THE INVENTION
FIBER SCAFFOLDS FOR ENHANCING CELL PROLIFERATION IN CELL
CULTURE
BACKGROUND OF THE INVENTION
[0001] The described invention relates in general to systems and devices for use in cell culture, and more specifically to a cell culture system and substrate that includes one or more polymer scaffolds adapted to be contained within a bioreactor, wherein the fiber scaffolds further include polymer fibers that have been created by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both.
[0002] Certain types of mammalian cells require attachment to a substrate so that they may adequately proliferate and undergo normal cellular function. These cells typically include a variety of stem or progenitor cells such as, for example, mesenchymal stem cells (MSC), and are of interest for a variety of clinical applications and therapies. However, the number of viable cells required for a typical therapeutic dose can be millions or billions per patient. Additionally, stem cells easily differentiate into other undesirable cell types while being expanded in vitro, thereby reducing the efficiency of the expansion process and creating a major problem for stem cell suppliers. Accordingly, there is a significant need for commercially available technologies that are capable of greatly expanding a relatively small number of stem or progenitor cells into a much larger population of such cells while maintaining the pluripotency thereof.
[0003] Current commercially used cell expansion processes typically involve large reusable stainless steel or glass bioreactors that must be cleaned and disinfected between batches or disposable, single-use bioreactors that resemble plastic bags. Stem cells are added to these bioreactors with appropriate media and reagents for promoting cell growth and then the bioreactors are closely monitored until a desired concentration of cells is achieved. For adherent cells, porous beads made from polystyrene and other polymers are added into the growth media and cell mixture to allow the cells to attach and grow normally. However, once the desired concentration of cells is achieved it is very difficult to remove all of the cells from the porous beads. This results in a low efficiency of usable cells for the desired end application. Therefore, there is an ongoing need for a cell culture system that permits desired cell growth and proliferation and that allows cultured cells to be harvested efficiently and in large numbers.
SUMMARY OF THE INVENTION
[0004] The following provides a summary of certain exemplary embodiments of the present invention. This summary is not an extensive overview and is not intended to identify key or critical aspects or elements of the present invention or to delineate its scope.
[0005] In accordance with one aspect of the present invention, a substrate for culturing cells is provided. This substrate includes at least one fiber scaffold adapted to be contained within a bioreactor. The fiber scaffold further includes polymer fibers that have been created by electrospinning and the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both.
[0006] In accordance with another aspect of the present invention, a system for culturing cells is provided. This system includes at least one fiber scaffold adapted to be contained within a bioreactor, and a bioreactor. The fiber scaffold further includes polymer fibers that have been created by electrospinning and the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both. The bioreactor may be disposable or permanent (i.e., reusable).
[0007] Additional features and aspects of the present invention will become apparent to those of ordinary skill in the art upon reading and understanding the following detailed description of the exemplary embodiments. As will be appreciated by the skilled artisan, further embodiments of the invention are possible without departing from the scope and spirit of the invention. Accordingly, the drawings and associated descriptions are to be regarded as illustrative and not restrictive in nature.
BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The accompanying Figures, which are incorporated into and form a part of the specification, illustrate one or more exemplary embodiments of the invention and, together with the general description given above and detailed description given below, serve to explain the principles of the invention, and wherein:
[0009] FIG. 1 is a photograph of exemplary polymer scaffolds of various shapes and sizes, in accordance with the present invention;
[0010] FIG. 2 is a photograph of exemplary polymer scaffolds of various shapes and sizes placed inside of a disposable bag bioreactor;
[0011] FIG. 3 is a photograph of randomly oriented polymer fibers deposited onto the surface of a disposable bag bioreactor;
[0012] FIG. 4 is a photograph of aligned polymer fibers deposited onto the surface of a disposable bag bioreactor;
[0013] FIG. 5 is a photograph of dispersed or free-floating fibers in solution;
[0014] FIG. 6 is a light microscope image of dispersed polymer fiber showing significantly more spacing between fibers than when in a consolidated mat or other structure;
[0015] FIG. 7 is a data graph illustrating the proliferation of human adipocyte-derived stem cells on different types of nanofibers, in accordance with the present invention;
[0016] FIG. 8 is a bar graph illustrating increased cell growth/expansion on the polymer fibers of the present invention;
[0017] FIGS. 9-12 are bar graphs presenting human induced pluripotent stem cell (iPSs) and embryonic stem cell (ECs) data;
[0018] FIGS. 13-14 are bar graphs that illustrate enhanced cell growth on nanofiber scaffolds made from a blend of PET and PU compared with plain PET and plain PU using human mesenchymal stem cells; and
[0019] FIG. 15 is a photograph of a polymer fiber having a core/shell construction. DETAILED DESCRIPTION OF THE INVENTION
[0018] Exemplary embodiments of the present invention are now described with reference to the Figures. Although the following detailed description contains many specifics for the purposes of illustration, a person of ordinary skill in the art will appreciate that many variations and alterations to the following details are within the scope of the invention. Accordingly, the following embodiments of the invention are set forth without any loss of generality to, and without imposing limitations upon, the claimed invention. With general reference to FIGS. 1-15, one or more specific embodiments of this invention shall now be described in greater detail.
[0019] In accordance with this invention, the process of electrospinning is driven by the application of a high voltage, typically between 0 and 30kV, to a droplet of a polymer solution or melt at a flow rate between 0 and 50ml/h to create a condition of charge separation between two electrodes and within the polymer solution to produce a polymer jet. A typical polymer solution includes a polymer such as polycaprolactone, polystyrene, or polyethersulfone and a solvent such as l,l,l,3,3,3-Hexafluoro-2-propanol, Ν,Ν-Dimethylformamide, acetone, or tetrahydrofuran in a concentration range of l-50wt%. As the jet of polymer solution travels toward the electrode it is elongated into small diameter fibers typically in the range of 0.1-30μιη.
[0020] In preparing an exemplary scaffold, a polymer nanofiber precursor solution is prepared by dissolving 9wt% polyethylene terephthalate (PET) (Indorama Ventures) in a mixture of nine parts 1,1,1,3,3,3-hexafluoroisopropanol (HFIP) and one part trifluoroacetic acid. The solution is heated to 60°C followed by continuous stirring to dissolve the PET. The solution is cooled to room temperature and placed in a syringe (e.g., 60cc) with a blunt tip needle (e.g., 20 gauge). The nanofibers are formed by electrospinning using a high voltage DC power supply (Glassman High Voltage, Inc., High Bridge, NJ) set to lkV-40kV (e.g., +15 kV) positive or negative polarity, a 5-30 cm (e.g., 15 cm) tip-to-substrate distance, and a Ιμΐ/hr to lOOmL/hr (e.g., 10 ml/hr) flow rate. It is possible to use a needle array including a large number of needles (e.g., >1000) to increase system output. The scaffold may be placed in a vacuum overnight and heated to ensure removal of residual solvent (typically less than 10 ppm) and treated using radio frequency gas plasma or corona for one second to one minute to make the fibers more hydrophilic and promote cell attachment thereto.
[0021] In accordance with this invention, it is possible to produce nanometer or micrometer sized fibers from a variety of synthetic and natural polymers. Suitable synthetic polymers include polycaprolactone (PCL), polyethylene terephthalate (PET), polystyrene (PS), polylactic acid (PLA), polyglycolic acid (PGA), polyurethane (PU), polyethersulfone, polyamide, Eudragit® (a polymerization of acrylic and methacrylic acids or their esters), polyetherketoneketone (PEKK), polyglycerol sebacate (PGS), polyhydroxybutyrate (PHB), trimethylene carbonate (TMC) and/or combinations thereof and/or derivatives thereof. Suitable natural polymers include gelatin, collagen, chitosan, fibrinogen, hyaluronic acid, cellulose, and/or combinations thereof and/or derivatives thereof. Suitable solvents may include acetone, dimethylformamide, trifluoroacetic acid, hexafluoroisopropanol, acetic acid, dimethylacetamide, chloroform, dichloromethane, water, ionic compounds, or combinations thereof. By predetermining the optimum fiber material and fiber diameter for each cell type or application, higher rates of cellular expansion, while maintaining a larger percentage of pluripotent cells, can be achieved as compared to other technologies.
[0022] The polymer fibers of this invention may include non-resorbable materials such as polyethylene, terephthalate, silicone, polyurethane, polycarbonate, polyether-ketoneketone, polyethersulfone, polyamide, polystyrene, Eudragit®, polyethylene terephthalate, polypropylene, or combinations thereof, and/or resorbable materials such as polycaprolactone (PCL), polylactic acid (PLA), polyglycolic acid (PGA), polyethylene terephthalate (PET) polypropylene (PP), or combinations thereof, and/or materials that may be preferentially dissolved by changes in pH, temperature or the addition of reagents to facilitate cell harvesting. Eudragit® is a pH sensitive polymer and Poly(N-isopropylacrylamide) is a thermo-responsive polymer that facilitates cell release from the fibers. The polymer fibers may be coated or otherwise treated with at least one compound that is operative to promote cellular attachment to the scaffold or to prohibit unwanted cell differentiation, and those compounds may include proteins, peptides, cytokines, small molecules (e.g., drugs) or combinations thereof. The polymer fibers of this invention may also include a core/shell construction which may be coated with a compound that promotes cell release therefrom.
[0023] The fiber scaffolds of the present invention may be used with bioreactors of different sizes and shapes, as well as those that are disposable or permanent (i.e., reusable). For the purpose of incorporating the fiber scaffolds of this invention into such bioreactors while still facilitating easy cell removal, fiber scaffolds of various sizes, shapes, and porosities may be utilized (see FIGS. 1-2). The polymer fibers in these scaffolds may be randomly arranged relative to one another or may be aligned with one another (see FIGS. 3-4). Depending on bioreactor geometry, the fiber scaffolds of this invention may be adhered to the bioreactor walls or other surfaces or may be dispersed, individual fibers that are free-floating in the cell culture media contained in a bioreactor (see FIGS. 5-6). These various fiber structures may be placed into the bioreactor at a manufacturing facility, sealed, sterilized, and then shipped to the customer. Alternately, these fiber structures may be sold separately and placed in the bioreactor by a person performing cell culture. To adhere polymer fiber to bioreactor bags, fiber is deposited directly onto the bag surface by placing a negatively charged substrate behind the bag or placing an anti-static bar behind the bag. This technique permits uniform deposition of the positively charged fibers onto the bag surface. Alternatively, the fibers may be attached to the bioreactor walls with adhesives, heat, laser welding, ultrasonic welding, or other methods.
[0024] In some embodiments of this invention, the fiber scaffold has been manufactured as a sheet of polymer fibers and then cut into pieces of at least one predetermined size prior to placement in the bioreactor. Cutting may be accomplished with scissors, a knife, or by tearing the polymer fiber sheet apart to form individual scaffolds of various sizes such as, for example,
3 3
about 1 mm fiber scaffolds to about 1 cm fiber scaffolds. For embodiments that utilize dispersed fibers, a tissue homogenizer may be used to chop and shred polymer fiber sheets, which then allows the fibers to then be fully dispersed in liquid.
[0025] FIG. 7 is a data graph illustrating the proliferation of human adipose-derived stem cells (hADSCs) on different types of nanofibers. Multiple replicates of hADSCs were seeded in 24-well plates containing five different randomly oriented three-dimensional nanofiber matrices. Seven days after initial seeding, the cells were trypsinized and re-suspended in culture media. Cell enumeration and viability was determined by trypan blue exclusion. Fold increases of hADSCs grown on three-dimensional nanofiber matrices relative to control cells grown on standard two-dimensional tissue culture polystyrene (TCPS) are quantified in FIG. 7. The data indicates that each three-dimensional nanofiber matrix supports the growth of hADSCs and results in a significant increase in expansion rates of cells compared to two dimensional TCPS.
[0026] FIG. 8 is a bar graph that illustrates increased cell growth/expansion on the polymer fibers of the present invention. With regard to the data appearing in FIG. 8, multiple replicates of human mesenchymal stem cells (hMSCs) were seeded in 24-well plates containing five different randomly oriented three-dimensional fiber matrices. Seven days after initial seeding, cells were trypsinized and resuspended in culture media. Cell enumeration and viability was determined by trypan blue exclusion. Fold increases of hMSCs grown on three dimensional matrices relative to control cells grown on standard 2D tissue culture polystyrene (TCPS) are shown in FIG. 8. The data indicate that each three-dimensional fiber matrix supports the growth of hMSCs and demonstrates a significant increase in the expansion rates of cells cultured in three dimensions compared to two dimensional TCPS.
[0027] FIGS. 9-12 are bar graphs presenting human induced pluripotent stem cell (iPSs) and embryonic stem cell (ECs) data. Embryonic stem cells typically need feeder cells or collagen on which to grow and the data in these Figures demonstrates nearly the same growth, but using a clean synthetic fiber scaffold. This feature of the present invention is important for cost reduction and translation to clinical therapies due to the superior control of the synthetic surface. FIGS. 13- 14 are bar graphs that illustrate enhanced cell growth on nanofiber scaffolds made from a blend of PET and PU compared with just PET and/or just PU using human MSCs. FIG. 15 is a photograph of a polymer fiber that is compatible with the present invention, wherein the fiber has a core/shell construction.
[0028] While the present invention has been illustrated by the description of exemplary embodiments thereof, and while the embodiments have been described in certain detail, it is not the intention of the Applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional advantages and modifications will readily appear to those skilled in the art. Therefore, the invention in its broader aspects is not limited to any of the specific details, representative devices and methods, and/or illustrative examples shown and described. Accordingly, departures may be made from such details without departing from the spirit or scope of the applicant's general inventive concept.

Claims

claimed:
A substrate for culturing cells, comprising at least one fiber scaffold adapted to be contained within a bioreactor, wherein the fiber scaffold further includes polymer fibers that have been created by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both.
The substrate of claim 1 , wherein the bioreactor is a disposable bioreactor.
The substrate of claim 1 , wherein the bioreactor is a non-disposable bioreactor.
The substrate of claim 1 , wherein the fiber scaffold is attached to at least one interior surface of the bioreactor.
The substrate of claim 1 , wherein the fiber scaffold is adapted to float freely in the bioreactor when the bioreactor is filled with cell culture media.
The substrate of claim 1 , where in the fiber scaffold has been manufactured as a sheet of polymer fibers, and wherein the sheet of polymer fibers has been cut into pieces of at least one predetermined size prior to placement in the bioreactor, and wherein the at least
3 3
one predetermined size ranges from about 1 mm to about 1 cm .
The substrate of claim 1 , wherein the fiber scaffold further includes independent fibers that are adapted to be dispersed in cell culture media used in a bioreactor.
The substrate of claim 1, wherein the polymer fibers have been coated or otherwise treated with at least compound that is operative to promote cellular attachment to the scaffold, and wherein the at least one compound further includes proteins, peptides, cytokines, small molecules, or combinations thereof. The substrate of claim 1 , wherein the polymer fibers further include synthetic polymers, and wherein the synthetic polymers further include polycaprolactone, polyethylene terephthalate, polystyrene, polylactic acid, polyglycolic acid, polyurethane,
polyethersulfone, polyamide, polyetherketoneketone, EUDRAGIT, polyglycerol sebacate, polyhydroxybutyrate, trimethylene carbonate, and combinations thereof or derivatives thereof.
The substrate of claim 1, wherein the polymer fibers further include natural polymers, and wherein the natural polymers further include gelatin, collagen, fibrinogen, hyaluronic acid, cellulose, and combinations thereof or derivatives thereof.
1) The substrate of claim 1, wherein the polymer fibers further include non-resorbable
materials, and wherein the non-resorbable materials further include polyethylene, terephthalate, silicone, polyurethane, polycarbonate, polyether-ketoneketone,
polyethersulfone, polyamide, polystyrene, EUDRAGIT, polyethylene terephthalate, polypropylene, or combinations thereof.
[2) The substrate of claim 1, wherein the polymer fibers further include resorbable materials, and wherein the resorbable materials further include polycaprolactone, polylactic acid, polyglycolic acid, trimethylene carbonate, polyhydroxylbutyrate, or combinations thereof.
3) The substrate of claim 1, wherein the polymer fibers further include materials that may be preferentially dissolved by changing pH, changing temperature, or by the addition of reagents that facilitate the harvesting of cells from the fibers.
4) A system for culturing cells, comprising:
(i) at least one fiber scaffold adapted to be contained within a bioreactor, wherein the fiber scaffold further includes polymer fibers that have been created by electrospinning, and wherein the orientation of the fibers in the scaffold relative to one another is generally parallel, random, or both; and
(ii) a bioreactor. The system of claim 14, wherein the bioreactor is a disposable bioreactor.
The system of claim 14, wherein the bioreactor is a non-disposable bioreactor.
The system of claim 14, wherein the fiber scaffold is attached to at least one interior surface of the bioreactor.
The system of claim 14, wherein the fiber scaffold is adapted to float freely in the bioreactor when the bioreactor is filled with cell culture media.
The system of claim 14, where in the fiber scaffold has been manufactured as a sheet of polymer fibers, and wherein the sheet of polymer fibers has been cut into pieces of at least one predetermined size prior to placement in the bioreactor.
The system of claim 14, wherein the fiber scaffold further includes independent fibers that are adapted to be dispersed in cell culture media used in a bioreactor.
The system of claim 14, wherein the polymer fibers have been coated or otherwise treated with at least compound that is operative to promote cellular attachment to the scaffold, and wherein the at least one compound further includes proteins, peptides, cytokines, small molecules, or combinations thereof.
The system of claim 14, wherein the polymer fibers further include synthetic polymers, and wherein the synthetic polymers further include polycaprolactone, polyethylene terephthalate, polystyrene, polylactic acid, polyglycolic acid, polyurethane,
polyethersulfone, polyamide, polyetherketoneketone, EUDRAGIT, polyglycerol sebacate, polyhydroxybutyrate, trimethylene carbonate, and combinations thereof or derivatives thereof.
The system of claim 14, wherein the polymer fibers further include natural polymers, and wherein the natural polymers further include gelatin, collagen, fibrinogen, hyaluronic acid, or cellulose, and combinations thereof or derivatives thereof. The system of claim 14, wherein the polymer fibers further include non-resorbable materials, and wherein the non-resorbable materials further include polyethylene, terephthalate, silicone, polyurethane, polycarbonate, polyether-ketoneketone,
polyethersulfone, polyamide, polystyrene, EUDRAGIT, polyethylene terephthalate, polypropylene, or combinations thereof.
The system of claim 14, wherein the polymer fibers further include resorbable materials, and wherein the resorbable materials further include polycaprolactone, polylactic acid, polyglycolic acid, polyhydroxybutyrate, trimethylene carbonate, or combinations thereof.
The system of claim 14, wherein the polymer fibers further include materials that may be preferentially dissolved by changing pH, changing temperature, or by the addition of reagents that facilitate the harvesting of cells from the fibers.
The system of claim 14, wherein the polymer fibers further include a core/shell construction.
PCT/US2013/055941 2012-08-21 2013-08-21 Fiber scaffolds for enhancing cell proliferation in cell culture WO2014031721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261691611P 2012-08-21 2012-08-21
US61/691,611 2012-08-21

Publications (1)

Publication Number Publication Date
WO2014031721A1 true WO2014031721A1 (en) 2014-02-27

Family

ID=49182482

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/055941 WO2014031721A1 (en) 2012-08-21 2013-08-21 Fiber scaffolds for enhancing cell proliferation in cell culture

Country Status (1)

Country Link
WO (1) WO2014031721A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737632B2 (en) 2013-09-25 2017-08-22 Nanofiber Solutions, Inc. Fiber scaffolds for use creating implantable structures
US9884027B2 (en) 2012-01-12 2018-02-06 Nanofiber Solutions, Inc. Nanofiber scaffolds for biological structures
US10166315B2 (en) 2015-05-04 2019-01-01 Nanofiber Solutions, Inc. Chitosan-enhanced electrospun fiber compositions
KR20190006367A (en) * 2017-07-10 2019-01-18 주식회사 아모라이프사이언스 SHEATH-CORE TYPE BICOMPONENT FIBER for cell culture scaffold AND FABRIC COMPRSING THE SAME
US10227568B2 (en) 2011-03-22 2019-03-12 Nanofiber Solutions, Llc Fiber scaffolds for use in esophageal prostheses
US10239262B2 (en) 2011-11-21 2019-03-26 Nanofiber Solutions, Llc Fiber scaffolds for use in tracheal prostheses
US10588734B2 (en) 2010-06-17 2020-03-17 Washington University Biomedical patches with aligned fibers
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US10682444B2 (en) 2012-09-21 2020-06-16 Washington University Biomedical patches with spatially arranged fibers
US10898608B2 (en) 2017-02-02 2021-01-26 Nanofiber Solutions, Llc Methods of improving bone-soft tissue healing using electrospun fibers
US10941375B2 (en) 2012-08-21 2021-03-09 Nanofiber Solutions, Llc Fiber scaffolds for enhancing cell proliferation in cell culture
US10953097B2 (en) 2015-11-02 2021-03-23 Nanofiber Solutions. Llc Electrospun fibers having contrast agents and methods of making the same
US11246959B2 (en) 2013-03-15 2022-02-15 Nanofiber Solutions, Llc Biocompatible fiber textiles for implantation
EP3795673A4 (en) * 2018-05-16 2022-02-23 Stem Cell & Device Laboratory, Inc. Cell scaffold material
US11576927B2 (en) 2018-12-11 2023-02-14 Nanofiber Solutions, Llc Methods of treating chronic wounds using electrospun fibers
CN116694565A (en) * 2023-05-29 2023-09-05 广州启源生物医药有限公司 Method for amplifying mesenchymal stem cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138552A2 (en) * 2005-06-15 2006-12-28 Government Of The Usa, As Represented By The Secretary, Dept. Of Health & Human Services Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same
WO2008137659A1 (en) * 2007-05-04 2008-11-13 University Of Virginia Patent Foundation Compositions and methods for making and using laminin nanofibers
WO2009089035A1 (en) * 2008-01-10 2009-07-16 Arteriocyte Inc. Methods and systems for expanding ac133+ cells and directing differentiation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006138552A2 (en) * 2005-06-15 2006-12-28 Government Of The Usa, As Represented By The Secretary, Dept. Of Health & Human Services Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same
WO2008137659A1 (en) * 2007-05-04 2008-11-13 University Of Virginia Patent Foundation Compositions and methods for making and using laminin nanofibers
WO2009089035A1 (en) * 2008-01-10 2009-07-16 Arteriocyte Inc. Methods and systems for expanding ac133+ cells and directing differentiation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HYUK SANG YOO ET AL: "Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery", ADVANCED DRUG DELIVERY REVIEWS, vol. 61, 1 January 2009 (2009-01-01), pages 1033 - 1042, XP055009070 *
LI W-J ET AL: "A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, vol. 26, no. 6, 1 February 2005 (2005-02-01), pages 599 - 609, XP025280436, ISSN: 0142-9612, [retrieved on 20050201], DOI: 10.1016/J.BIOMATERIALS.2004.03.005 *
SOMAIEH KAZEMNEJAD ET AL: "Biochemical and molecular characterization of hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 24, no. 2, 1 February 2009 (2009-02-01), pages 278 - 287, XP055084180, ISSN: 0815-9319, DOI: 10.1111/j.1440-1746.2008.05530.x *

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11096772B1 (en) 2010-06-17 2021-08-24 Washington University Biomedical patches with aligned fibers
US11471260B2 (en) 2010-06-17 2022-10-18 Washington University Biomedical patches with aligned fibers
US11311366B2 (en) 2010-06-17 2022-04-26 Washington University Biomedical patches with aligned fibers
US10888409B2 (en) 2010-06-17 2021-01-12 Washington University Biomedical patches with aligned fibers
US11000358B2 (en) 2010-06-17 2021-05-11 Washington University Biomedical patches with aligned fibers
US11071617B2 (en) 2010-06-17 2021-07-27 Washington University Biomedical patches with aligned fibers
US10588734B2 (en) 2010-06-17 2020-03-17 Washington University Biomedical patches with aligned fibers
US10617512B2 (en) 2010-06-17 2020-04-14 Washington University Biomedical patches with aligned fibers
US10227568B2 (en) 2011-03-22 2019-03-12 Nanofiber Solutions, Llc Fiber scaffolds for use in esophageal prostheses
US10233427B2 (en) 2011-03-22 2019-03-19 Nanofiber Solutions, Llc Fiber scaffolds for use in esophageal prostheses
US10239262B2 (en) 2011-11-21 2019-03-26 Nanofiber Solutions, Llc Fiber scaffolds for use in tracheal prostheses
US10562225B2 (en) 2011-11-21 2020-02-18 Nanofiber Solutions, Llc System for manufacturing fiber scaffolds for use in tracheal prostheses
US10653635B2 (en) 2012-01-12 2020-05-19 Nanofiber Solutions, Llc Nanofiber scaffolds for biological structures
US11737990B2 (en) 2012-01-12 2023-08-29 Nfs Ip Holdings, Llc Nanofiber scaffolds for biological structures
US9884027B2 (en) 2012-01-12 2018-02-06 Nanofiber Solutions, Inc. Nanofiber scaffolds for biological structures
US10941375B2 (en) 2012-08-21 2021-03-09 Nanofiber Solutions, Llc Fiber scaffolds for enhancing cell proliferation in cell culture
US11253635B2 (en) 2012-09-21 2022-02-22 Washington University Three dimensional electrospun biomedical patch for facilitating tissue repair
US10682444B2 (en) 2012-09-21 2020-06-16 Washington University Biomedical patches with spatially arranged fibers
US11596717B2 (en) 2012-09-21 2023-03-07 Washington University Three dimensional electrospun biomedical patch for facilitating tissue repair
US11173234B2 (en) 2012-09-21 2021-11-16 Washington University Biomedical patches with spatially arranged fibers
US11246959B2 (en) 2013-03-15 2022-02-15 Nanofiber Solutions, Llc Biocompatible fiber textiles for implantation
US9737632B2 (en) 2013-09-25 2017-08-22 Nanofiber Solutions, Inc. Fiber scaffolds for use creating implantable structures
US10166315B2 (en) 2015-05-04 2019-01-01 Nanofiber Solutions, Inc. Chitosan-enhanced electrospun fiber compositions
US10953097B2 (en) 2015-11-02 2021-03-23 Nanofiber Solutions. Llc Electrospun fibers having contrast agents and methods of making the same
US11224677B2 (en) 2016-05-12 2022-01-18 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US10632228B2 (en) 2016-05-12 2020-04-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US11826487B2 (en) 2016-05-12 2023-11-28 Acera Surgical, Inc. Tissue substitute materials and methods for tissue repair
US10898608B2 (en) 2017-02-02 2021-01-26 Nanofiber Solutions, Llc Methods of improving bone-soft tissue healing using electrospun fibers
US11806440B2 (en) 2017-02-02 2023-11-07 Nfs Ip Holdings, Llc Methods of improving bone-soft tissue healing using electrospun fibers
KR102386537B1 (en) 2017-07-10 2022-04-15 주식회사 아모라이프사이언스 SHEATH-CORE TYPE BICOMPONENT FIBER for cell culture scaffold AND FABRIC COMPRSING THE SAME
KR20190006367A (en) * 2017-07-10 2019-01-18 주식회사 아모라이프사이언스 SHEATH-CORE TYPE BICOMPONENT FIBER for cell culture scaffold AND FABRIC COMPRSING THE SAME
EP3795673A4 (en) * 2018-05-16 2022-02-23 Stem Cell & Device Laboratory, Inc. Cell scaffold material
US11576927B2 (en) 2018-12-11 2023-02-14 Nanofiber Solutions, Llc Methods of treating chronic wounds using electrospun fibers
CN116694565A (en) * 2023-05-29 2023-09-05 广州启源生物医药有限公司 Method for amplifying mesenchymal stem cells

Similar Documents

Publication Publication Date Title
US10941375B2 (en) Fiber scaffolds for enhancing cell proliferation in cell culture
WO2014031721A1 (en) Fiber scaffolds for enhancing cell proliferation in cell culture
US11737990B2 (en) Nanofiber scaffolds for biological structures
DK2739720T3 (en) Devices and methods for growing cells
EP2971318B1 (en) Biocompatible fiber textiles for implantation
US20210189329A1 (en) Production of extracellular vesicles from stem cells
US20140193374A1 (en) Methods and compositions for culturing cells
Morelli et al. Microtube array membrane bioreactor promotes neuronal differentiation and orientation
Wang et al. Biomimetic three‐dimensional anisotropic geometries by uniaxial stretching of poly (ε‐caprolactone) films: Degradation and mesenchymal stem cell responses
Bettahalli et al. Development of multilayer constructs for tissue engineering
JP2015223111A (en) Methods and apparatuses for long term perfusion of high density cell culture
Selvam et al. Microporous poly (L-lactic acid) membranes fabricated by polyethylene glycol solvent-cast/particulate leaching technique
EP3795673A1 (en) Cell scaffold material
Ko et al. Surface modification of PHBV nanofiber mats for rapid cell cultivation and harvesting
Zheng et al. Liquid Crystal Modified Polylactic Acid Improves Cytocompatibility and M2 Polarization of Macrophages to Promote Osteogenesis
Gonçalves et al. Potential of Electrospun Fibrous Scaffolds for Intestinal, Skin, and Lung Epithelial Tissue Modeling
Silva Cellular proliferation in 3D Tissue Engineering scaffolds made of polymeric nano-fibers
Vasyliev et al. NanoMatrix3D® nanofibrous scaffolds for tissue engineering approaches
Sahlolbei et al. Differentiation of Human Mesenchymal Stem Cell into Chonderocyte Like Cells 3D Poly Lactic Acid Glycosaminoglycan (PCL-GAG) Nano Fibre Scaffold

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13762919

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13762919

Country of ref document: EP

Kind code of ref document: A1